ConfidenHT System for Diagnostic Electrical Mapping of Renal Nerves
NCT02777216 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2018-02-26
Summary
To evaluate the safety and performance of the ConfidenHT System
Conditions
Interventions
- DEVICE
-
ConfidenHT system
ConfidenHT Medical system
Sponsors & Collaborators
-
BlueWind Medical
lead INDUSTRY
Principal Investigators
-
Kostas Tsioufis, MD · Hippocratio Hospital, Athens, Greece
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-10-31
- Primary Completion
- 2017-11-30
- Completion
- 2017-12-31
Countries
- Greece
- Netherlands
Study Locations
More Related Trials
-
Mechanisms and Phenotypes of Hypertension in Patients in Chronic Hemodialysis
NCT06764277 ·Status: COMPLETED
-
A Study of Non-Vascular Renal Denervation Using the Verve Medical Phoenix ™ System
NCT05440513 ·Status: UNKNOWN ·Phase: NA
-
Blood Pressure Measurement in Dialysed Patients
NCT03318653 ·Status: COMPLETED
-
Influence Continuous Veno-venous Hemodialysis the Autoregulation
NCT01376531 ·Status: COMPLETED
-
Data on the Prevention of Complications of Prophylactic Intravenous Hydration in Patients With eGFR < 30
NCT04592406 ·Status: COMPLETED
-
Drugmonitoring of Antiinfective Drugs in Patients Receiving Continous Veno-venous Hemodiafiltration (ABx-CVVHDF)
NCT02242721 ·Status: WITHDRAWN
-
A Prospective, Multicenter, Randomized, Blinded, Sham-controlled, Feasibility Study of Renal Denervation in Patients With Chronic Heart Failure
NCT04947670 ·Status: TERMINATED ·Phase: NA
-
A Prospective Danish National Registry of PTRA in Patients With Renovascular Hypertension
NCT02770066 ·Status: RECRUITING
-
A Randomized Trial of Six-Channel RF Ablation System for Renal Denervation in Uncontrolled Hypertension and Chronic Kidney Disease
NCT07130955 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
DENEX Renal Denervation in Patients With Hypertension on no Antihypertensive Medications
NCT04535050 ·Status: RECRUITING ·Phase: NA
-
RenalGuard System for Prevention of Contrast Induced Nephropathy
NCT02029820 ·Status: UNKNOWN ·Phase: PHASE3
-
Monitoring Renal Blood Flow With Contrast Enhanced Ultrasound During Coronary Angiogram
NCT01544036 ·Status: UNKNOWN ·Phase: NA
-
Quantification of Autonomic Nervous Activity During Hemodialysis
NCT02754986 ·Status: COMPLETED ·Phase: NA
-
Search About Contributing Factors That Leading to Intradialytic Hypertension in Hemodialysis Patients
NCT07069491 ·Status: RECRUITING
-
Biomarkers of Cardiovascular Complications in Chronic Kidney Disease
NCT03274921 ·Status: COMPLETED
-
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
NCT01456013 ·Status: UNKNOWN ·Phase: PHASE3
-
Establishing a New Ultrasound Technique to Improve Assessment of Chronic Kidney Disease.
NCT06159439 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
CITrate and Evodial for Effective Dialysis (CITED) Study
NCT02281045 ·Status: COMPLETED ·Phase: NA
-
GFR Measurement With Contrast-enhanced Dynamic MRI
NCT00614081 ·Status: COMPLETED ·Phase: NA
-
The Efficacy of Color-Doppler Ultrasonography to Assess the Renal Blood Flow With the Estimation of GFR
NCT00470769 ·Status: UNKNOWN
-
Hand-carried Ultrasound to Assess Hydronephrosis
NCT03774719 ·Status: TERMINATED ·Phase: NA
-
Surrogate Markers for Sudden Cardiac Death in Patients With Diabetes Mellitus and End Stage Renal Disease
NCT02001480 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Endothelial Dysfunction Using the "Flow Mediated Dilation" Test in a Population of Chronic Renal Failure Patients at Different Stages, and Evaluation of the Role of Antiphospholipid Antibodies
NCT06347029 ·Status: RECRUITING ·Phase: NA
-
Multiparametric MRI in Healthy Volunteers and CKD Patients
NCT05229263 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Cerebral Blood Flow During Hemodialysis
NCT02272985 ·Status: COMPLETED ·Phase: NA